Estimation of Long‐Term Efficacy of Denosumab Treatment in Postmenopausal Women With Osteoporosis: A FRAX‐ and Virtual Twin‐Based Post Hoc Analysis From the FREEDOM and FREEDOM Extension Trials

The 3‐year placebo‐controlled FREEDOM (Fracture REduction Evaluation of Denosumab in Osteoporosis Every 6 Months) trial established the antifracture efficacy of denosumab in postmenopausal women with osteoporosis. The 7‐year open‐label extension demonstrated that denosumab treatment for up to 10 yea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JBMR Plus
Main Authors: Siris, Ethel, McDermott, Michele, Pannacciulli, Nicola, Miller, Paul D, Lewiecki, E Michael, Chapurlat, Roland, Jódar‐Gimeno, Esteban, Huang, Shuang, Kanis, John A
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2020
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7117843/
https://ncbi.nlm.nih.gov/pubmed/32258966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10348
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados